|
|||||
|
|
The economic burden of atherothrombosis in Greece: results from the THESIS study |
|
| Authors: | Nikos Maniadakis Georgia Kourlaba Dennis V. Cokkinos Aggeliki Angeli John Kyriopoulos |
| Affiliation: | 1. Department of Health Services Organization and Management, National School of Public Health, 196 Alexandras Avenue, 115 21, Athens, Greece 5. Department of Health Services Management, National School of Public Health, 196, Alexandras Ave, 11522, Athens, Greece 2. Onassis Cardiac Surgery Center, Biomedical Research Foundation Academy of Athens, 356 Syngrou Avenue, 17674, Athens, Greece 3. Institutional Relations and Communication Department, Sanofi-Aventis Greece, 348 A Syngrou Avenue, 176 74, Athens, Greece 4. Department of Health Economics, National School of Public Health, 196 Alexandras Avenue, 115 21, Athens, Greece |
| Abstract: | The aim of this study was to estimate the total annual cost of patients with or at risk for atherothrombosis in Greece. A multicentre, cost-of-illness study was conducted between January 2007 and December 2009. In the study, 800 patients with coronary artery disease, cerebrovascular disease, or peripheral artery disease (PAD) or multiple cardiovascular risk factors (MRF) were recruited. Direct and indirect cost data were assessed at patients’ enrolment in the study, and at 6 and 12 months of follow-up. The annual total cost was €6,017/patient. This cost ranged from €10,098/patient with PAD to €1,813/patient with MRF. The annual direct health-care cost was €5,056/patient. This cost escalates from €1,623/patient with MRF to €8,697/patient with PAD. The total annual expenditures related to atherothrombosis, in Greece, were estimated to be €7.5 billion at the national level. The findings of the current study indicate the high economic burden of atherothrombosis in Greece. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |